Ambala: Haryana Effectively being Minister Anil Vij, who had tested sure for coronavirus no longer too lengthy within the past, has been shifted to the PGIMS health center at Rohtak from the civil health center here after he complained of discomfort, doctors acknowledged on Sunday.
Medical doctors acknowledged the minister turned into as soon as shifted on Saturday evening. Ambala’s civil surgeon Dr Kuldeep Singh acknowledged a team of doctors at the Rohtak health center turned into as soon as monitoring his situation.
Vij, who had final month obtained one shot of the two-dose trial of the COVID-19 vaccine Covaxin after he supplied to be a volunteer, had on 5 December tested sure for the coronavirus.
The 67-year-standard BJP chief had supplied to be the necessary volunteer within the section three trials for Covaxin, an indigenous capacity vaccine being developed by Bharat Biotech towards COVID-19.
He turned into as soon as administered the dose on 20 November at the Civil Sanatorium in Ambala Cantonment, about 50 kilometres from Chandigarh.
Bharat Biotech had acknowledged that scientific trials of the vaccine are based totally on a two-dose agenda, given 28 days apart. The vaccine efficacy will be optimistic two weeks after the second dose, it acknowledged.
COVAXIN has been designed to be protective two weeks after volunteers receive the 2nd dose.
The Union Effectively being Ministry had additionally stepped in to speak that Covaxin is a two-dose anti-coronavirus vaccine and that Vij turned into as soon as given easiest the necessary dose a fortnight before he tested sure.
“The antibodies towards the infection intention up in a human being easiest after a suppose series of days pass after the second dose of the vaccine is taken. Here’s a two-dose vaccine. The minister in query has taken easiest one dose of the vaccine,” the ministry had acknowledged in a assertion..
Vij had earlier acknowledged he had gone to Panipat just a few days within the past where he spent 2-3 hours with a BJP chief, who too had tested sure for COVID-19.